Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Silver

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Opinion in Obstetrics & Gynecology|October 4, 2023
Genetic risk assessment in breast and gynecologic malignancies- what's to know in 2024?Daniella Kamara, Erica Silver, Mariana Niell-Swiller
Clinical Breast Cancer|May 11, 2019
Implementing a Population-Based Breast Cancer Risk Assessment ProgramErica Silver, Neil Wenger, Zhuoer Xie, et al.
JAMA Internal Medicine|December 12, 2025
Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical TrialKirkpatrick B Fergus, Katherine S Ross, Maren T Scheuner, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Opinion in Obstetrics & Gynecology|October 4, 2023
Genetic risk assessment in breast and gynecologic malignancies- what's to know in 2024?Daniella Kamara, Erica Silver, Mariana Niell-Swiller
Clinical Breast Cancer|May 11, 2019
Implementing a Population-Based Breast Cancer Risk Assessment ProgramErica Silver, Neil Wenger, Zhuoer Xie, et al.
JAMA Internal Medicine|December 12, 2025
Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical TrialKirkpatrick B Fergus, Katherine S Ross, Maren T Scheuner, et al.
Pageof 1